Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BVS NASDAQ:INMD NASDAQ:PRCT NASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$11.80+2.8%$10.01$5.81▼$12.53$985.71M0.65701,257 shs472,858 shsINMDInMode$15.17+0.5%$14.25$12.72▼$16.74$871.99M1.91640,828 shs419,196 shsPRCTPROCEPT BioRobotics$16.69-4.9%$23.34$16.67▼$58.87$949.98M0.871.49 million shs1.89 million shsTMCITreace Medical Concepts$4.00-1.2%$3.88$1.17▼$7.78$259.49M1.37822,334 shs242,329 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus+2.79%-2.16%+24.21%+16.95%+82.38%INMDInMode+0.53%-1.94%+2.57%+5.35%+1.61%PRCTPROCEPT BioRobotics-4.90%-13.16%-19.95%-31.49%-72.21%TMCITreace Medical Concepts-1.23%-6.98%-3.15%+102.02%-34.21%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$11.80+2.8%$10.01$5.81▼$12.53$985.71M0.65701,257 shs472,858 shsINMDInMode$15.17+0.5%$14.25$12.72▼$16.74$871.99M1.91640,828 shs419,196 shsPRCTPROCEPT BioRobotics$16.69-4.9%$23.34$16.67▼$58.87$949.98M0.871.49 million shs1.89 million shsTMCITreace Medical Concepts$4.00-1.2%$3.88$1.17▼$7.78$259.49M1.37822,334 shs242,329 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus+2.79%-2.16%+24.21%+16.95%+82.38%INMDInMode+0.53%-1.94%+2.57%+5.35%+1.61%PRCTPROCEPT BioRobotics-4.90%-13.16%-19.95%-31.49%-72.21%TMCITreace Medical Concepts-1.23%-6.98%-3.15%+102.02%-34.21%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 3.00Buy$14.7525.00% UpsideINMDInMode 2.00Hold$16.005.47% UpsidePRCTPROCEPT BioRobotics 2.33Hold$37.27123.32% UpsideTMCITreace Medical Concepts 1.86Reduce$4.9724.25% UpsideCurrent Analyst Ratings BreakdownLatest TMCI, PRCT, BVS, and INMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026PRCTPROCEPT BioRobotics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/16/2026TMCITreace Medical Concepts Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$2.00 ➝ $4.007/2/2026PRCTPROCEPT BioRobotics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Hold$30.00 ➝ $25.007/2/2026PRCTPROCEPT BioRobotics CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold6/30/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$14.006/24/2026PRCTPROCEPT BioRobotics EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$30.006/24/2026PRCTPROCEPT BioRobotics EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$30.006/16/2026BVSBioventus Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.006/15/2026TMCITreace Medical Concepts Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/11/2026PRCTPROCEPT BioRobotics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$31.00 ➝ $29.006/2/2026BVSBioventus Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)(Data available from 7/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$568.09M1.74$1.31 per share9.00$2.76 per share4.28INMDInMode$374.64M2.33$1.50 per share10.11$10.78 per share1.41PRCTPROCEPT BioRobotics$322.02M2.95N/AN/A$6.55 per share2.55TMCITreace Medical Concepts$207.32M1.25N/AN/A$1.37 per share2.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus$22.73M$0.4128.7813.261.464.94%29.97%9.52%N/AINMDInMode$93.83M$1.3611.15N/AN/A23.27%13.47%11.95%N/APRCTPROCEPT BioRobotics-$95.57M-$1.82N/AN/AN/A-31.82%-27.70%-20.29%8/4/2026 (Estimated)TMCITreace Medical Concepts-$59M-$0.97N/AN/AN/A-29.44%-67.04%-30.28%8/6/2026 (Estimated)Latest TMCI, PRCT, BVS, and INMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026TMCITreace Medical Concepts-$0.30N/AN/AN/A$44.02 millionN/A8/4/2026Q2 2026PRCTPROCEPT BioRobotics-$0.46N/AN/AN/A$92.64 millionN/A5/8/2026Q1 2026TMCITreace Medical Concepts-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million5/6/2026Q1 2026BVSBioventus$0.09$0.15+$0.06$0.04N/A$132.09 million5/6/2026Q1 2026INMDInMode$0.2978$0.25-$0.0478$0.18$79.84 million$82.02 million4/29/2026Q1 2026PRCTPROCEPT BioRobotics-$0.55-$0.56-$0.01-$0.56$80.52 million$83.13 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.081.691.13INMDInModeN/A8.807.88PRCTPROCEPT BioRobotics0.156.735.51TMCITreace Medical Concepts0.723.582.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%INMDInMode68.04%PRCTPROCEPT BioRobotics89.46%TMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipBVSBioventus33.50%INMDInMode6.92%PRCTPROCEPT BioRobotics4.00%TMCITreace Medical Concepts23.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20083.54 million55.55 millionN/AINMDInMode48057.48 million53.50 millionOptionablePRCTPROCEPT BioRobotics43056.92 million54.64 millionOptionableTMCITreace Medical Concepts25064.87 million49.68 millionOptionableTMCI, PRCT, BVS, and INMD HeadlinesRecent News About These CompaniesDid Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?July 24 at 2:24 PM | prnewswire.comTreace to Report Second Quarter 2026 Financial Results on August 7, 2026July 24 at 7:05 AM | globenewswire.comWhy Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%July 23 at 7:19 AM | aaii.comAAnalyzing Atossa Genetics (NASDAQ:ATOS) and Treace Medical Concepts (NASDAQ:TMCI)July 23 at 2:58 AM | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from AnalystsJuly 22 at 3:45 AM | americanbankingnews.comTreace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst SaysJuly 18, 2026 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from BrokeragesJuly 17, 2026 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Given New $4.00 Price Target at Truist FinancialJuly 16, 2026 | marketbeat.comFinancial Comparison: Treace Medical Concepts (NASDAQ:TMCI) versus Tactile Systems Technology (NASDAQ:TCMD)July 16, 2026 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in JuneJuly 15, 2026 | marketbeat.comJohnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)July 13, 2026 | globenewswire.comTMCI Share News TodayJune 30, 2026 | uk.investing.comTreace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant SystemJune 18, 2026 | globenewswire.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 22,887 SharesJune 12, 2026 | insidertrades.comTreace to Present at the Sidoti Small Cap ConferenceJune 11, 2026 | globenewswire.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 50,000 SharesJune 2, 2026 | insidertrades.comTreace Medical Concepts Balances Growth With Earnings StrainJune 1, 2026 | tipranks.comJohn Treace Purchases 4,508 Shares of Treace Medical Concepts (NASDAQ:TMCI) StockMay 29, 2026 | insidertrades.comTreace Medical Shareholders Back Directors, Pay and AuditorMay 20, 2026 | tipranks.comTreace Medical Concepts, Inc.May 15, 2026 | edition.cnn.comTreace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 43,000 SharesMay 15, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTMCI, PRCT, BVS, and INMD Company DescriptionsBioventus NASDAQ:BVS$11.80 +0.32 (+2.79%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$11.80 0.00 (0.00%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.InMode NASDAQ:INMD$15.17 +0.08 (+0.53%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$15.18 +0.02 (+0.10%) As of 07/24/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.PROCEPT BioRobotics NASDAQ:PRCT$16.69 -0.86 (-4.90%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$16.99 +0.30 (+1.79%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.Treace Medical Concepts NASDAQ:TMCI$4.00 -0.05 (-1.23%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$4.00 0.00 (0.00%) As of 07/24/2026 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
